Phase II and Biologic Study of Interferon Alfa, Retinoic Acid, and Cisplatin in Advanced Squamous Skin Cancer

医学 中性粒细胞减少症 内科学 顺铂 胃肠病学 毒性 白细胞减少症 进行性疾病 化疗 α-干扰素 临床研究阶段 癌症 外科 肿瘤科 免疫疗法
作者
Dong M. Shin,Bonnie S. Glisson,Fadlo R. Khuri,John L. Clifford,Gary L. Clayman,Steven E. Benner,Arlene A. Forastiere,Lawrence E. Ginsberg,Diane Liu,J. Jack Lee,Jeffrey N. Myers,Helmuth Goepfert,Reuben Lotan,Waun Ki Hong,Scott M. Lippman
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:20 (2): 364-370 被引量:96
标识
DOI:10.1200/jco.2002.20.2.364
摘要

PURPOSE: The purpose of this study was to test interferon alfa (IFNα), 13-cis-retinoic acid (13cRA), and cisplatin biochemotherapy in advanced squamous cell carcinoma (SCC) of the skin. PATIENTS AND METHODS: Patients with advanced skin SCC received IFNα (5 × 10 6 IU/m 2 , subcutaneous injection, three times a week), 13cRA (1 mg/kg, orally, daily), and cisplatin (20 mg/m 2 , intravenous injection, weekly) in a phase II trial. The growth inhibition, cell-cycle, and apoptosis activity of these agents was evaluated in two skin SCC cell lines (SRB1-m7 and SRB12-p9). RESULTS: Thirty-nine patients were enrolled. All were assessable for survival, 35 for response and toxicity (median follow-up was 38 months). The overall and complete response rates were 34% and 17%, respectively, with median durations of 9 and 35.4 months, respectively. The response rate was higher in locally advanced (67%) than metastatic (17%) disease (P = .007). Median survival was 14.6 months. One-, 2-, and 5-year survival rate estimates were 58%, 32%, and 21%, respectively. Toxicity included generally mild to moderate fatigue and mucocutaneous dryness, moderate to severe neutropenia (38%), and neutropenic fever (6%). There were no treatment-related deaths. In vitro growth inhibition and apoptosis effects of cisplatin were differential and inversely associated with those of retinoic acid and especially IFNα in two skin SCC lines. CONCLUSION: The rising incidence, morbidity, and mortality of advanced skin SCC are a major challenge for clinical oncologists. Combined 13cRA, IFNα, and cisplatin was clinically active in extensive locally advanced disease. Each agent had independent, non–cross-resistant biologic effects in vitro, which may account for the combination’s clinical activity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
闵不悔完成签到,获得积分10
1秒前
阳光火车完成签到 ,获得积分10
2秒前
cc完成签到,获得积分10
5秒前
合适的寄灵完成签到 ,获得积分10
6秒前
量子星尘发布了新的文献求助10
7秒前
科研通AI5应助cc采纳,获得10
8秒前
铜泰妍完成签到 ,获得积分10
9秒前
贝贝完成签到 ,获得积分10
14秒前
Lrcx完成签到 ,获得积分10
15秒前
Wen完成签到 ,获得积分10
16秒前
盘尼西林完成签到 ,获得积分10
18秒前
LOVE0077完成签到,获得积分10
21秒前
zhao完成签到,获得积分10
23秒前
BINBIN完成签到 ,获得积分10
33秒前
ambrose37完成签到 ,获得积分10
35秒前
量子星尘发布了新的文献求助10
41秒前
fufufu123完成签到 ,获得积分10
45秒前
开心的大娘完成签到,获得积分10
45秒前
www完成签到 ,获得积分10
47秒前
末末完成签到 ,获得积分10
57秒前
无为完成签到 ,获得积分10
58秒前
白嫖论文完成签到 ,获得积分10
1分钟前
上官若男应助忧伤的步美采纳,获得10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
1分钟前
从心随缘完成签到 ,获得积分10
1分钟前
花花发布了新的文献求助10
1分钟前
牛奶面包完成签到 ,获得积分10
1分钟前
1分钟前
岁月如歌完成签到 ,获得积分0
1分钟前
1分钟前
Li完成签到,获得积分10
1分钟前
张琨完成签到 ,获得积分10
1分钟前
1分钟前
sunnyqqz完成签到,获得积分10
1分钟前
热情的乘风完成签到,获得积分20
1分钟前
1分钟前
霍凡白完成签到,获得积分10
1分钟前
1分钟前
Feng发布了新的文献求助20
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038039
求助须知:如何正确求助?哪些是违规求助? 3575756
关于积分的说明 11373782
捐赠科研通 3305574
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022